McKenzie, S. K. & Kronauer, D. J. C. The genomic architecture and molecular evolution of ant odorant receptors. Genome Res. 28, 1757–1765 (2018).
Pushker, R., Mira, A. & Rodriguez-Valera, F. Comparative genomics of gene-family size in closely related bacteria. Genome Biol. 5, R27 (2004).
Deitsch, K. W., Lukehart, S. A. & Stringer, J. R. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7, 493–503 (2009).
Cannon, S. B., Mitra, A., Baumgarten, A., Young, N. D. & May, G. The roles of segmental and tandem gene duplication in the evolution of large gene families in Arabidopsis thaliana. BMC Plant Biol. 4, 10 (2004).
Schwartze, V. U. et al. Gene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina). PLoS Genet. 10, e1004496 (2014).
Berna, L. et al. Expanding an expanded genome: long-read sequencing of Trypanosoma cruzi. Microb. Genom. 4, e000177 (2018).
Hoyos Sanchez, M. C. et al. A phased genome assembly of a Colombian Trypanosoma cruzi TcI strain and the evolution of gene families. Sci. Rep. 14, 2054 (2024).
Wang, W. et al. Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease. PLoS Pathog. 17, e1009254 (2021).
De Pablos, L. M. & Osuna, A. Multigene families in Trypanosoma cruzi and their role in infectivity. Infect. Immun. 80, 2258–2264 (2012).
Hotez, P. J. et al. An unfolding tragedy of Chagas disease in North America. PLoS Negl. Trop. Dis. 7, e2300 (2013).
Ferreira, A. V. et al. Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes Infect. 13, 1002–1005 (2011).
Tarleton, R. L., Zhang, L. & Downs, M. O. Autoimmune rejection” of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 94, 3932–3937 (1997).
Almeida, I. C., Ferguson, M. A., Schenkman, S. & Travassos, L. R. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304, 793–802 (1994).
Tarleton, R. L. CD8+ T cells in Trypanosoma cruzi infection. Semin. Immunopathol. 37, 233–238 (2015).
Tarleton, R. L., Koller, B. H., Latour, A. & Postan, M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356, 338–340 (1992).
Leavey, J. K. & Tarleton, R. L. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J. Immunol. 170, 2264–2268 (2003).
Rosenberg, C. S., Zhang, W., Bustamante, J. M. & Tarleton, R. L. Long-term immunity to trypanosoma cruzi in the absence of immunodominant trans-sialidase-specific CD8+ T cells. Infect. Immun. 84, 2627–2638 (2016).
Martins, F. A. et al. The recombinant form of Trypanosoma cruzi P21 controls infection by modulating host immune response. Front Immunol. 11, 1010 (2020).
Tasso, L. M. et al. Effect of the Tc13Tul antigen from Trypanosoma cruzi on splenocytes from naive mice. Parasitology 147, 1114–1123 (2020).
Ruiz Diaz, P. et al. Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells. Infect. Immun. 83, 2099–2108 (2015).
Burle-Caldas, G. A. et al. Disruption of active trans-sialidase genes impairs egress from mammalian host cells and generates highly attenuated Trypanosoma cruzi Parasites. mBio 13, e0347821 (2022).
Medina-Rincon, G. J. et al. Molecular and clinical aspects of chronic manifestations in Chagas disease: a state-of-the-art review. Pathogens 10, 1493 (2021).
Altamura, F., Rajesh, R., Catta-Preta, C. M. C., Moretti, N. S. & Cestari, I. The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets. Drug Dev. Res. 83, 225–252 (2022).
Nakayasu, E. S. et al. GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi. Mol. Syst. Biol. 5, 261 (2009).
Buscaglia, C. A. et al. The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins. J. Biol. Chem. 279, 15860–15869 (2004).
Magdesian, M. H. et al. Infection by Trypanosoma cruzi: identifying a parasite ligand its host cell receptor. J. Biol. Chem. 276, 19382–19389 (2001).
Pollevick, G. D. et al. Trypanosoma cruzi surface mucins with exposed variant epitopes. J. Biol. Chem. 275, 27671–27680 (2000).
Santori, F. R. et al. Identification of a domain of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 required for attachment and invasion of mammalian cells. Mol. Biochem. Parasitol. 78, 209–216 (1996).
Schenkman, S., Jiang, M. S., Hart, G. W. & Nussenzweig, V. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 65, 1117–1125 (1991).
Schenkman, S., Pontes de Carvalho, L. & Nussenzweig, V. Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes. J. Exp. Med. 175, 567–575 (1992).
Tomlinson, S., Pontes de Carvalho, L. C., Vandekerckhove, F. & Nussenzweig, V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J. Immunol. 153, 3141–3147 (1994).
Rodrigues, J. P. F. et al. Host cell protein LAMP-2 is the receptor for Trypanosoma cruzi surface molecule gp82 that mediates invasion. Cell Microbiol. 21, e13003 (2019).
Onofre, T. S., Loch, L., Ferreira Rodrigues, J. P., Macedo, S. & Yoshida, N. Gp35/50 mucin molecules of Trypanosoma cruzi metacyclic forms that mediate host cell invasion interact with annexin A2. PLoS Negl. Trop. Dis. 16, e0010788 (2022).
Chuenkova, M. V. & PereiraPerrin, M. Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy. Sci. Signal 2, ra74 (2009).
Mucci, J. et al. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Proc. Natl. Acad. Sci. USA 99, 3896–3901 (2002).
Risso, M. G., Pitcovsky, T. A., Caccuri, R. L., Campetella, O. & Leguizamon, M. S. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections. Parasitology 134, 503–510 (2007).
Poveda, C. et al. Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). PLoS One 9, e91154 (2014).
Talavera-Lopez, C. et al. Repeat-driven generation of antigenic diversity in a major human pathogen, Trypanosoma cruzi. Front Cell Infect. Microbiol 11, 614665 (2021).
Franzen, O. et al. Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener. PLoS Negl. Trop. Dis. 5, e984 (2011).
El-Sayed, N. M. et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309, 409–415 (2005).
Teixeira, S. M., Russell, D. G., Kirchhoff, L. V. & Donelson, J. E. A differentially expressed gene family encoding “amastin,” a surface protein of Trypanosoma cruzi amastigotes. J. Biol. Chem. 269, 20509–20516 (1994).
Pinazo, M. J. et al. Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial. Lancet Infect. Dis. 24, 395–403 (2024).
Atwood, J. A. et al. The Trypanosoma cruzi proteome. Science 309, 473–476 (2005).
Inchausti, L. et al. Single-cell RNA-seq reveals trans-sialidase-like superfamily gene expression heterogeneity in Trypanosoma cruzi populations. eLife 14, RP105822 (2025).
Laidlaw, R. et al. The Trypanosoma cruzi Cell Atlas; a single-cell resource for understanding parasite population heterogeneity and differentiation. Preprint at https://doi.org/10.1101/2024.10.01.616042 (2025).
Mugnier, M. R., Cross, G. A. & Papavasiliou, F. N. The in vivo dynamics of antigenic variation in Trypanosoma brucei. Science 347, 1470–1473 (2015).
Touray, A. O., Sternlieb, T., Isebe, T. & Cestari, I. Identifying antigenic switching by clonal cell barcoding and nanopore sequencing in Trypanosoma brucei. Bio Protoc. 13, e4904 (2023).
Heslop, R. et al. Genome-wide libraries for protozoan pathogen drug target screening using yeast surface display. ACS Infect. Dis. 9, 1078–1091 (2023).
Boder, E. T. & Wittrup, K. D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553–557 (1997).
Reis-Cunha, J. L. et al. Accessing the variability of multicopy genes in complex genomes using unassembled next-generation sequencing reads: the case of Trypanosoma cruzi multigene families. mBio 13, e0231922 (2022).
Freitas, L. M. et al. Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity. PLoS One 6, e25914 (2011).
Diaz-Viraque, F., Chiribao, M. L., Libisch, M. G. & Robello, C. Genome-wide chromatin interaction map for Trypanosoma cruzi. Nat. Microbiol. 8, 2103–2114 (2023).
Jager, A. V., Muia, R. P. & Campetella, O. Stage-specific expression of Trypanosoma cruzi trans-sialidase involves highly conserved 3’ untranslated regions. FEMS Microbiol. Lett. 283, 182–188 (2008).
Li, Z. H. et al. A 43-nucleotide U-rich element in 3’-untranslated region of large number of Trypanosoma cruzi transcripts is important for mRNA abundance in intracellular amastigotes. J. Biol. Chem. 287, 19058–19069 (2012).
Tsai, A., Alves, M. R. & Crocker, J. Multi-enhancer transcriptional hubs confer phenotypic robustness. Elife 8, e45325 (2019).
Sanchez-Valdez, F. J., Padilla, A., Wang, W., Orr, D. & Tarleton, R. L. Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure. Elife 7, e34039 (2018).
Ferragut, F., Acevedo, G. R. & Gomez, K. A. T cell specificity: a great challenge in Chagas disease. Front. Immunol. 12, 674078 (2021).
Acevedo, G. R. et al. In silico guided discovery of novel class I and II Trypanosoma cruzi epitopes recognized by T cells from Chagas’ disease patients. J. Immunol. 204, 1571–1581 (2020).
Cestari, I. & Stuart, K. Transcriptional regulation of telomeric expression sites and antigenic variation in trypanosomes. Curr. Genom. 19, 119–132 (2018).
Sadigursky, M. & Brodskyn, C. I. A new liquid medium without blood and serum for culture of hemoflagellates. Am. J. Trop. Med. Hyg. 35, 942–944 (1986).
Cruz-Saavedra, L. et al. Purification of Trypanosoma cruzi metacyclic trypomastigotes by ion exchange chromatography in sepharose-DEAE, a novel methodology for host-pathogen interaction studies. J. Microbiol. Methods 142, 27–32 (2017).
Cheng, H., Concepcion, G. T., Feng, X., Zhang, H. & Li, H. Haplotype-resolved de novo assembly using phased assembly graphs with hifiasm. Nat. Methods 18, 170–175 (2021).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Ghurye, J., Pop, M., Koren, S., Bickhart, D. & Chin, C. S. Scaffolding of long read assemblies using long range contact information. BMC Genom. 18, 527 (2017).
Tarailo-Graovac M., Chen N. Using RepeatMasker to identify repetitive elements in genomic sequences. Curr. Protoc. Bioinformatics 4, 11–14 (2009).
Tello, D. et al. NGSEP3: accurate variant calling across species and sequencing protocols. Bioinformatics 35, 4716–4723 (2019).
Reis-Cunha, J. L. et al. Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU. BMC Genom. 19, 816 (2018).
Sternlieb T., Loock M., Gao M., Cestari I. Efficient generation of genome-wide libraries for protein-ligand screens using Gibson assembly. Bio Protoc. 12, (2022).
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
Open2C et al. Pairtools: from sequencing data to chromosome contacts. PLoS Comput. Biol. 20, e1012164 (2024).
Schwabl, P. et al. Meiotic sex in Chagas disease parasite Trypanosoma cruzi. Nat. Commun. 10, 3972 (2019).
McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150–7158 (2014).
Golizeh, M. et al. New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice. Heliyon 8, e12380 (2022).
Sambrook J., Russell D. W. Molecular Cloning: A Laboratory Manual, 3rd edn. (Cold Spring Harbor Laboratory Press, 2001).
Sternlieb, T., Loock, M., Gao, M. & Cestari, I. Efficient generation of genome-wide libraries for protein-ligand screens using Gibson assembly. Bio. Protoc. 13, e4747 (2023).
